비비나비 : 로스앤젤레스 : (미국) Los Angeles

CDC and global partners continue the fight against antimicrobial resistance.
October 8, 2024
 
United Nations High-level Meeting on Antimicrobial Resistance
On September 26, global leaders participated in the United Nations General Assembly High-level Meeting on Antimicrobial Resistance. CDC Deputy Director/Chief Strategy Officer Andi Fristedt (pictured above) delivered the U.S. statement on antimicrobial resistance in a multi-stakeholder panel. She was accompanied by Dan Jernigan, Director of CDC’s National Center for Emerging and Zoonotic Infectious Diseases (pictured behind Andi).




Leaders adopted a political declaration, which establishes global goals, commitments, and targets in combating antimicrobial resistance, including a goal to reduce global deaths associated with bacterial antimicrobial resistance by 10% by 2030. In addition, the political declaration identifies specific infection prevention interventions in healthcare and communities, including:Immunization (reduces infections and antimicrobial use)
Early and accurate detection of pathogens
Infection prevention and control
Water, sanitation, and hygiene (WASH)

CDC helps build capacity in more than 50 countries to detect antimicrobial-resistant pathogens, prevent infections in healthcare and the community, and apply new and innovative ways to respond to antimicrobial resistance threats.






































                           
 
Antimicrobial Resistance Causes and How It Spreads

Antimicrobial resistance happens when germs develop the ability to defeat the drugs designed to kill them. That means the germs are not killed and continue to grow. Resistant infections can be difficult, and sometimes impossible, to treat.




Antimicrobial resistance is an urgent global public health threat.






                           
                             
Improving Antimicrobial Resistance Detection in Ukraine to Slow Global Spread

The war in Ukraine has stressed Ukraine's health systems, creating an environment where antimicrobial-resistant bacteria can thrive and quickly spread within the country and across borders.


CDC and global partners are supporting the government of Ukraine to improve laboratory practices in the country, an important first step to protect people from antimicrobial resistance.




                           
                             
Innovative Studies Investigate Spread of Antimicrobial Resistance 

CDC supports innovative studies to investigate high-risk, antimicrobial-resistant pathogens in Bangladesh, Botswana, Chile, Guatemala, India, and Kenya. 

                           
                             
A TB-Free India: Stopping TB before it Spreads

Drug-resistant tuberculosis (TB) is a leading cause of illness, death, and economic loss due to antimicrobial resistance. CDC works to prevent, diagnose, and treat all forms of TB. In India, CDC and partners joined forces to bring the country one step closer to ending TB.
 
                           
                             
CDC’s Global Health Strategic Framework

Investments to combat antimicrobial resistance globally align with the six core public health capabilities outlined in CDC's Global Health Strategic Framework.




No matter the threat, we know we need the right data and surveillance; laboratories; workforce and institutions; prevention and response; innovation and research; and policy, communications, and diplomacy.


                           
                           
 
Related PublicationsAntimicrobial resistance at a crossroads: the cost of inaction - The Lancet






































 
Related WebpagesGlobal Antimicrobial Resistance Laboratory and Response Network
International Infection Control Resources
Ending Drug-resistant TB






































 
Subscribe to this newsletter
 
















Centers for Disease Control and Prevention
1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348Questions or Problems  |  Unsubscribe